BeOne Medicines AG
ONC
$316.99
-$5.38-1.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 286.93M | 68.55M | -177.64M | -392.37M | -644.79M |
| Total Depreciation and Amortization | 131.68M | 146.31M | 180.67M | 174.55M | 167.03M |
| Total Amortization of Deferred Charges | 24.88M | 9.64M | 9.29M | 4.72M | 4.73M |
| Total Other Non-Cash Items | 493.19M | 552.41M | 519.96M | 504.95M | 489.56M |
| Change in Net Operating Assets | 190.90M | 8.48M | 38.93M | -79.84M | -157.17M |
| Cash from Operations | 1.13B | 785.39M | 571.21M | 212.02M | -140.63M |
| Capital Expenditure | -185.84M | -240.80M | -326.37M | -392.49M | -492.66M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -90.32M | -90.63M | -89.67M | -67.97M | -55.69M |
| Cash from Investing | -276.16M | -331.43M | -416.03M | -460.46M | -548.35M |
| Total Debt Issued | 1.08B | 765.38M | 765.38M | 806.24M | 877.32M |
| Total Debt Repaid | -1.08B | -854.02M | -853.32M | -905.80M | -732.25M |
| Issuance of Common Stock | 196.28M | 185.83M | 121.52M | 93.94M | 45.37M |
| Repurchase of Common Stock | -24.20M | -24.20M | -24.20M | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -14.49M | -14.49M | -14.49M |
| Other Financing Activities | 883.56M | 885.00M | 0.00 | 3.00M | 3.00M |
| Cash from Financing | 1.06B | 958.00M | 9.39M | -2.62M | 193.45M |
| Foreign Exchange rate Adjustments | 60.02M | -14.85M | 3.59M | -25.79M | -51.71M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.97B | 1.40B | 168.16M | -276.85M | -547.24M |